TAVERAS ARTHUR (Chief Scientific Officer) sold 16.5% of their position (76.92K shares) of X4 PHARMACEUTICALS, INC on the open market
Open‑market sale worth $43.3K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/8/2024ACC: 0001628280-24-042541
Officer· Chief Scientific Officer
Since Nov 2020
+153.72K
Net shares
Net buyer
$43.3K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
230.65K acquired · 76.92K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+230.65K
Price / share
—
Trade value
—
% of position
98.4%
10/4/2024
234.30K→464.95K
Common Stock
Direct
Shares
−76.92K
Price / share
$0.56
Trade value
$43.31K
% of position
16.5%
10/7/2024
464.95K→388.03K
Total
Net shares
+153.72K
Net value
-$43.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/4/2024 | A · Award | +230.65K | — | — | 98.4% | 234.30K | 464.95K |
| Common Stock Direct | 10/7/2024 | S · Sale | −76.92K | $0.56 | $43.31K | 16.5% | 464.95K | 388.03K |
| Total | +153.72K | -$43.31K | ||||||
Derivative Transactions0
No derivative transactions reported